BIOAVAILABILITY OF PREDNISOLONE IN PATIENTS WITH INTESTINAL MALABSORPTION - THE IMPORTANCE OF MEASURING SERUM PROTEIN-BINDING

被引：23

作者：

BERGREM, H

OPEDAL, I

机构：

[1] NATL HOSP NORWAY,DEPT MED A,OSLO,NORWAY

[2] NATL HOSP NORWAY,DEPT CLIN PHARMACOL,OSLO,NORWAY

来源：

关键词：

D O I：

10.3109/00365528309181635

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：545 / 549

页数：5

共 8 条

[1]

BEHM HL, 1979, RES COMMUN CHEM PATH, V26, P145

[2]

BERGREM H, 1983, EUR J CLIN PHARM

[3]

BERGREM H, 1983, KIDNEY INT

[4]

BERGREM H, 1981, SCAND J UROL NEPHR S, V64, P167

[5] PHARMACOKINETICS OF DRUGS IN PATIENTS WITH NEPHROTIC SYNDROME [J].

GUGLER, R ;

SHOEMAN, DW ;

HUFFMAN, DH ;

COHLMIA, JB ;

AZARNOFF, DL .

[6]

PARSONS RL, 1981, DRUG ABSORPTION, P262

[7]

PICKUP ME, 1979, EUROPEAN J DRUG META, V2, P87

TANNER, AR ;

HALLIDAY, JW ;

POWELL, LW .